HNHacker News
TopNewBestAskShowJobs

xr4ti

144 karma · joined July 16, 2017

submissionscomments
xr4ti··on Apple scientists disclose self-driving car research
It's actually probably an easier sell outside of major population centers, especially if marketed as an advanced form of cruise control, which people already use on long, straight shots down country highways.

I think people would be much more inclined to trust self driving tech in these scenarios than in congested traffic with complex intersections and people unexpectedly darting this way and that with little to no warning.

xr4ti··on Apple scientists disclose self-driving car research
Then perhaps it should not be advertised as "autopilot".
xr4ti··on Apple scientists disclose self-driving car research
Sure. That way they can partner with insurers to offer lower rates to people who buy their tech. Pretty sound business strategy.

I understand that this is a pretty cynical view, and to be fair all the Googlers I've spoken with are true believers in their tech (perhaps a little too much). But don't underestimate the power of ego and financial incentives to constrain ethical/moral calculus.

xr4ti··on Apple scientists disclose self-driving car research
A big difference is accountability. If you get into an accident and kill someone while playing a mobile game or taking a medication that says, "do not operate heavy machinery while taking this," it's clear who is at fault, and it is relatively easy for the state and injured parties seek sanction and redress through the justice system.

So what about an algorithm that has been given the regulatory green light and fails under some edge case or adversarial attack? How about something like the Tesla situation, where they advertise "self-driving" capabilities while tucking in some liability limiting fine print about how the driver should be alert and ready to take over control at all times?

xr4ti··on The Problem of Doctors’ Salaries
Good comment. One disagreement I have is the implicit dichotomy that it's either the doctors or the insurance companies who are soaking the patients/consumers, and not both.

Both the MDs and the insurance companies are rife with a number of rotten incentives and bad actors that contribute to expensive medical care without quality commensurate with costs.

In fact, the entire policy debate over risk-based vs fee-for-service payment models is essentially the payers and providers arguing over who gets to rip you off.

xr4ti··on She Warned of ‘Peer-To-Peer Misinformation.’ Congress Listened
I said it in another comment, but ability to spoof source and identity at scale.

Last time I checked, the NY Times was still publishing as the NY Times and placing their writers' names on the byline. When someone catches them printing up counterfeit copies of the Wall Street Journal designed to discredit we can talk about some sort of equivalence.

xr4ti··on She Warned of ‘Peer-To-Peer Misinformation.’ Congress Listened
The difference is the ease and scale with which identity and source can be hidden or spoofed to exploit trust relationships and herd instincts on the internet.

Whether something is white (e.g. RT, Voice of America, etc), grey (e.g. swift boat vets for truth, astroturfed citizens for X), or black hat propaganda (e.g. Black Matters, @TEN_GOP) depends on whether you represent yourself as (a) yourself, (b) a neutral party, or (c) your adversary.

So yeah, the problem is one of policing identity rather than messages. In other words, how do we make it more difficult for people to get catfished?

xr4ti··on Swagger is now the OpenAPI Specification
Hi! Can you detail some of the problems you have with SOAP? I'm superficially familiar with Swagger, but probably below the level of dilettante when it comes knowing about SOAs in general.
xr4ti··on Google’s plan to revolutionise cities is a takeover in all but name
> Its executives have floated the idea of taking some struggling city – Detroit? – and reinventing it around Alphabet services, with no annoying regulations blocking this march of progress.

This is pretty much exactly the plot of Robocop. https://en.wikipedia.org/wiki/RoboCop

xr4ti··on The Sound in Havana: What Americans Heard in Cuba Attacks
You got a more descriptive caption for the imgur link?
xr4ti··on An impossibility theorem for gerrymandering
>So the question is if "Minimizing Efficiency Gap" is what we should be aiming for.

100% agree. I think this can be further broken down into the questions:

(1) What are the problems caused by extreme gerrymandering?

(2) How will efficiency gap minimization alleviate these problems?

(3) What assumptions are we making in (2)? How likely are they to be true? And how robust is the solution to their falsification?

(4) How could this all go catastrophically wrong?

My intuition is that efficiency gap minimization is an incomplete solution and probably should be only one of several factors considered.

xr4ti··on Beijing Pushes for a Direct Hand in Big Chinese Tech Firms
I'll be very interested to see how this plays out over the long term.

Positive:

- Adds the voice of a civic minded, non-profit entity to the board. Maybe less brutal than pure capitalism?

- Less risk of Frankenstein's monster (e.g. dual use adware)

Negative:

- Govt is now married to them, and the tech graveyards are littered with the corpses of behemoths who lost their edge.

xr4ti··on My Institutional Review Board Nightmare
Said this in another comment, but I'll reiterate here. The big difference is purpose/intent. Looking under the hood of someone's car can be totally fine or a violation depending on whether or not I'm being paid to fix it.

Same thing applies here. In one case the questions are being asked to provide treatment the patient is paying for. In the other it's being done to collect data for a publication.

xr4ti··on My Institutional Review Board Nightmare
Yes, but there is a key distinction between the practice of medicine and clinical experimentation. The first is (in theory) is done for the benefit of the patient receiving treatment. The second is done to test a hypothesis.

Putting a patient at risk to treat them (e.g. chemotherapy) is very different than putting them at risk to get data for a publication or NDA. There's no reason what's tolerable in one context should be in the other.

xr4ti··on My Institutional Review Board Nightmare
(A) This is kind of a red herring though. The rules are not uniform. Sick patients require more protections than healthy adults. Placing an implant in someone's leg requires a more comprehensive risk minimization plan than asking someone to look at the ground for 5 seconds and then read a flash card.

(B) Is the lack of risk really self-evident? To everyone? Or just to you? Thus the question who should decide? And by what process do they decide?

xr4ti··on My Institutional Review Board Nightmare
Well a few simple questions about deep seated emotional trauma (e.g. molestation), or embarrassing or taboo subjects can present risks to patients. So like you say. Sometimes.

The question is who decides and how they make the decision? Surely it should involve someone other than the investigator, and have clearly defined rules so people know what to expect. Hence the IRB.

xr4ti··on My Institutional Review Board Nightmare
(A) The rules are not arbitrary. They are the product of much careful deliberation.

https://en.wikipedia.org/wiki/Belmont_Report

(B) Is experimentation on suicidal patients really minimal risk? Maybe, maybe not. But failure of the investigator to show they have thought about it is a huge red flag.

xr4ti··on My Institutional Review Board Nightmare
I can't agree. The authors wounds at every stage in the narrative were self inflicted.

(1) The study title doesn't work at the top of the form? Change it! Surely there is some other arrangement of English words that would satisfy both the author and IRB.

(2) They leave the risk section blank because minimal risk, and then complain about the requirement for pens because the patients might stab themselves if given pens. Looks to me like they didn't spend much effort thinking about risks to the patient. If they had just mentioned the pen stabby thing as a risk factor, and given "don't use pens" as a risk minimization plan, they wouldn't have had a problem.

(3) They poopoo the training because Hitler, and then get upset when they unknowingly violate a personnel rule that is most definitely covered in any decent IRB/GCP training.

I could go on, but every new thing I enumerate makes me angrier. Life is too short. Look. IRB applications suck, but human experimentation is serious business.

The rules aren't there to make the study easy, the are there to (a) look out for the patient (respect), (b) evaluate risk and benefits of the study (beneficence), and (c) ensure that the benefits are distributed to the group bearing the risk (justice).

xr4ti··on The Decline of Investment in San Francisco Startups
Yes. Thugs. Drugs. Drive by shootings. The east bay is a burning trash heap with no redeeming value. Please do not move here.
← PreviousPage 2 of 2